Private label manufacturer VitaTech International, Inc. announces reaffirmation of its FDA pharmaceutical licensing and investment in new production capabilities for the manufacturing of tablets, powders and two-piece capsules. “We remain committed to leading the industry in quality control, rapid turnaround and cost-effective manufacturing solutions for our customers,” said CEO Thomas T. Tierney, who attributes the company’s growth to customer focus. “We stay ahead of customer wants and regulatory needs, he says. “We place a premium on personalized customer service.”
The company continues to drive up its production capacity, providing rapid turnaround to high-volume customers. New high-speed equipment enables VitaTech to press an additional 250,000 tablets per hour, bringing capacity to 3.8 billion tablets per year.
In packaging, over $2 million was invested in state-of-the-art tablet and capsule fillers. With the installation of segregated overhead feed systems and new technology to automatically reject non-conforming tablets and capsules, VitaTech added speed and quality assurance.
The company has expanded encapsulation production, with capacity of up to 1.2 billion capsules annually. Recent investments in quality control and EDI solutions provide faster turnaround times, improved data accuracy and streamlined interactions with trading partners.
Leading the West Coast in capacity for continuous coating of vitamins and nutraceuticals, VitaTech also provides comprehensive analytical testing services. Heavy metals and microbiological testing are available on-site in the company’s quality assurance/quality control analytical laboratory.